Wednesday, March 05, 2025 | 05:14 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Lupin plunges 6% as June quarter profit tanks 60% YoY to Rs 107 crore

EBITDA tood at Rs 531.4 cror for the quarter under review, down 34.7 per cent, from Rs 813.4 crore of Q1FY20, and by 27.6 per from Rs 733.9 crore logged in Q4FY20

The Company filed 4 ANDAs during the quarter and received 4 ANDA approvals from the US FDA
Premium

The Company filed 4 ANDAs during the quarter and received 4 ANDA approvals from the US FDA

SI Reporter New Delhi
Shares of Lupin Ltd plummeted up to 6.2 per cent to Rs 878.15 per share on the BSE on Friday after the pharmaceutical company's net profit for April-June quarter declined 60 per cent on a yearly basis to Rs 106.9 crore. Lupin had posted a profit of Rs 264.7 crore in the corresponding period of the previous year. 

On a quarterly basis, profit tanked 72.6 per cent from Rs 389.6 crore in the March quarter of FY20. That apart, EBITDA (earnings before interest, tax, depreciation and amortisation) stood at Rs 531.4 cror for the quarter under review, down 34.7 per cent,

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in